CareRx (FRA:29C1) E10: €-0.57 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:29C1 CareRx Corp FRA:29C1
66 GF Score
Price €2.04
GF Value €1.37
! 3 Warning Signs
View Full Analysis

What is CareRx E10?

CareRx FRA:29C1 66 E10 is €-0.57 as of Jun. 2026. GuruFocus rates FRA:29C1 with a GF Score™ of 66/100 and a GF Value™ of €1.37. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CareRx's adjusted earnings per share data for the three months ended in Jun. 2026 was €0.006. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.57 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 27.50% per year. During the past 5 years, the average E10 Growth Rate was 28.00% per year. During the past 10 years, the average E10 Growth Rate was 8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of CareRx was 46.20% per year. The lowest was -102.30% per year. And the median was -3.20% per year.

As of today (2026-08-10), CareRx's current stock price is €2.04. CareRx's E10 for the quarter that ended in Jun. 2026 was €-0.57. CareRx's Shiller PE Ratio of today is .


CareRx  (FRA:29C1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CareRx E10 Related Terms


CareRx E10 Historical Data

* Premium members only.

The historical data trend for CareRx's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CareRx E10 Chart

CareRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -710.42 -1,603.08 -0.99 -0.33 -0.78

CareRx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 -0.08 -0.78 -0.69 -0.57

FRA:29C1 vs HCA, THC, DVA: E10 Comparison

For the Medical Care Facilities subindustry, CareRx's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareRx Shiller PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareRx's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CareRx's Shiller PE Ratio falls into.


FRA:29C1
66GF Score
CareRx Corp FRA:29C1
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CareRx E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CareRx's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.006/133.5265*133.5265
=0.006

Current CPI (Jun. 2026) = 133.5265.

CareRx Quarterly Data

per share eps CPI Adj_EPS
201609 0.272 101.765 0.357
201612 -0.142 101.449 -0.187
201703 -0.279 102.634 -0.363
201706 0.134 103.029 0.174
201709 0.012 103.345 0.016
201712 0.265 103.345 0.342
201803 -0.125 105.004 -0.159
201806 -1.304 105.557 -1.650
201809 -0.132 105.636 -0.167
201812 -0.523 105.399 -0.663
201903 -0.397 106.979 -0.496
201906 -0.107 107.690 -0.133
201909 -0.226 107.611 -0.280
201912 -1.148 107.769 -1.422
202003 0.143 107.927 0.177
202006 -0.491 108.401 -0.605
202009 -0.180 108.164 -0.222
202012 0.001 108.559 0.001
202103 -0.140 110.298 -0.169
202106 -0.190 111.720 -0.227
202109 -0.074 112.905 -0.088
202112 -0.048 113.774 -0.056
202203 -0.043 117.646 -0.049
202206 -0.392 120.806 -0.433
202209 -0.030 120.648 -0.033
202212 -0.063 120.964 -0.070
202303 -0.027 122.702 -0.029
202306 0.021 124.203 0.023
202309 -0.014 125.230 -0.015
202312 -0.041 125.072 -0.044
202403 -0.007 126.258 -0.007
202406 -0.014 127.522 -0.015
202409 -0.007 127.285 -0.007
202412 -0.020 127.364 -0.021
202503 0.000 129.181 0.000
202506 0.006 129.892 0.006
202509 0.012 130.287 0.012
202512 0.229 130.366 0.235
202603 0.013 132.262 0.013
202606 0.006 133.527 0.006

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.57 mean?
CareRx (FRA:29C1) has a E10 of €-0.57 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on CareRx and its competitors.
Is CareRx's E10 too high?
CareRx's current E10 is €-0.57. Overall, CareRx has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does CareRx's E10 compare to HCA and THC?
CareRx's E10 of €-0.57 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Healthcare Providers & Services company?
A good E10 depends on the Healthcare Providers & Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on CareRx and its competitors. CareRx's current E10 is €-0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareRx stock overvalued right now?
CareRx (FRA:29C1) has a current E10 of €-0.57. The stock's GF Value™ is €1.37, compared to a current price of €2.04 — trading 48.9% above its estimated fair value. The current E10 is €-0.57. CareRx's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For CareRx (FRA:29C1), the current E10 is €-0.57 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CareRx (FRA:29C1) Overvalued in 2026?

Based on GuruFocus' analysis, CareRx stock appears to be overvalued. The current stock price of €2.04 is trading 48.9% above its estimated GF Value™ of €1.37.

Key valuation signals for FRA:29C1:

  • E10: €-0.57
  • GF Value™: €1.37 vs. price of €2.04 (48.9% above fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the FRA:29C1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CareRx Business Description

Other Exchanges CHHHF:USACRRX:Canada
Address 320 Bay Street, Suite 1200, Toronto, ON, CAN, M5H 4A6
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
66GF Score

Get the complete analysis for FRA:29C1

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.04
Price
€1.37
GF Value